CTOs on the Move

Kerr Corp

www.kerrdental.com

 
Kerr Corporation, a subsidiary of Sybron Dental Specialties, is a manufacturer of premiere dental consumables sold both domestically and internationally. Since 1891, Kerr has been developing, manufacturing and products that are used in every dental
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

The Washington Home

The Washington Home is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Washington Home is based in Hagerstown, MD. You can find more information on The Washington Home at www.thewashingtonhome.org

MD Business Solutions

MD Business Solutions is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wisteria Cottage

Wisteria Cottage is a Sequim, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Solera Health

Solera is changing lives by guiding people to better health solutions that work. Solera`s value-based technology platform enables successful interventions that address the most prevalent and costly chronic conditions. Solera matches consumers to their best-fit solution within carefully curated networks of digital and community-based point solutions and drives superior engagement and outcomes by managing performance. Solera`s technology platform serves payers and employers by streamlining, integrating, and creating accountability in the point solution ecosystem.

Naveos

NAVEOS® is the proven leader in maximizing the value of governmental program reimbursements for healthcare providers. Since 2005, our superior approach to data analytics has enabled healthcare providers to realize almost one billion dollars in additional DSH/340B reimbursement payments. NAVEOS® has developed a fully integrated DSH/340B software solution with a national eligibility verification network for both Medicare and Medicaid data. This system, which is the most robust in the industry, uses sophisticated algorithms to match eligibility data with patient data, applies the most up to date Federal and State regulatory parameters, then builds comprehensive deliverables for supporting DSH/340B filings. By leveraging our state-of-the-art technology and unsurpassed domain expertise, we generate best-in-class deliverables that yield impressive value and achieve a stellar (99.7%) audit acceptance rate.